7 Results for "

NALM6

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "NALM6" in MCE Product Catalog:

Cat. No.: HY-116170
CAS No.: 1548116-54-6
Target:  

17β-HSD

Research Areas:  

Cancer

SN34037 is a specific inhibitor of Aldo-keto reductase 1C3 (AKR1C3, EC 1.1.1.188) with the ability to inhibit the cytotoxic activity of PR-104A. SN34037-sensitive coumberone reduction provides a rapid and specific assay for AKR1C3 activity. SN34037 inhibits the aerobic cytotoxicity of PR-104A in TF1 erythroleukemia cells with high AKR1C3 expression, but not in Nalm6 pre-B acute lymphoblastic leukemia cells with low AKR1C3 expression .
loading...
    loading...
Cat. No.: HY-N16567
CAS No.: 820975-61-9
Acrofolione A is an acetophenone dimer isolated from Acronychia pendunculata with anticancer effects. Acrofolione A induces G0/G1 phase cell cycle arrest and apoptosis in human NALM-6 pre-B cell leukaemia cells. Acrofolione A can be used for leukaemia research .
loading...
    loading...
Cat. No.: HY-W588247
CAS No.: 364083-21-6
Synonyms: SF-cysteine
Target:  

Drug Metabolite

Research Areas:  

Cancer

S-(N-Methylsulfinylbutylthiocarbamoyl)-L-cysteine (SF-cysteine), a metabolite of Sulforaphane (HY-13755), can enhance the survival rate of Nalm-6 cells .
loading...
    loading...
Cat. No.: HY-150797
Synonyms: QA-68-ZU81
QA-68 (QA-68-ZU81) is an effective PROTAC-class BRD9 degrader. QA-68 can inhibit cell cycle progression and cell colony formation. QA-68 has antiproliferative activity against acute myeloid leukemia (AML) cell lines
loading...
    loading...
Cat. No.: HY-188021
Target:  

mRNA CD22

Research Areas:  

Cancer

cis a chimeric antigen receptor mRNA targeting CD22. When delivered via CD8-targeted LNP, CD22 CAR mRNA inhibits tumor growth in Nalm6 tumor-bearing mouse models. CD22 CAR mRNA can be used for research on hematologic malignancies .
loading...
    loading...
Cat. No.: HY-P991839

Target:  

CD19

Research Areas:  

Cancer

Anti-CD19 Antibody (FMC63) is an antibody that binds to CD19, with a human Kd value ranging from 0.42 nM to 149 nM. Anti-CD19 Antibody (FMC63) mediates tumor cell killing, cytokine secretion, stable CAR expression, T cell activation and memory differentiation. Anti-CD19 Antibody (FMC63) fails to eliminate lymphoma cells carrying CD19 point mutations or co-expressing FMC63-CAR19, induces higher levels of activation-induced cell death, and reduces cell persistence. Anti-CD19 Antibody (FMC63) can be used in research related to B-cell non-Hodgkin's lymphoma, B-cell acute lymphoblastic leukemia, relapsed or refractory diffuse large B-cell lymphoma, etc .
loading...
    loading...
Cat. No.: HY-181976
Research Areas:  

Others

dHTC3 is a selective BRD4 molecular glue degrader. dHTC3 specifically recruits the first bromodomain of BRD4 to the E3 ubiquitin ligase complex (SCF FBXO3), thereby triggering the ubiquitination and degradation of BRD4 .
loading...
    loading...